TY - JOUR AU - Meeuse, Jan J. AU - Sprenger, Herman G. AU - van Assen, Sander AU - Leduc, Dominique AU - Daenen, Simon M.G.J. AU - Arends, Jan P. AU - van der Werf, Tjip S. T1 - Rhodococcus equi Infection after Alemtuzumab Therapy for T-cell Prolymphocytic Leukemia T2 - Emerging Infectious Disease journal PY - 2007 VL - 13 IS - 12 SP - 1942 SN - 1080-6059 AB - Rhodococcus equi, mainly known from veterinary medicine as a pathogen in domestic animals, can also cause infections in immunocompromised humans, especially in those with defects in cellular immunity. Alemtuzumab, an anti-CD52 monoclonal antibody, causes lymphocytopenia by eliminating CD52-positive cells. We report a patient in whom Rhodococcus equi infection developed after alemtuzumab therapy. KW - Rhodococcus equi KW - Alemtuzumab KW - T-PLL KW - dispatch KW - the Netherlands DO - 10.3201/eid1312.061559 UR - https://wwwnc.cdc.gov/eid/article/13/12/06-1559_article ER - End of Reference